GeneDx (WGS) Competitors $64.90 +2.59 (+4.15%) As of 02:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock WGS vs. HIMS, GH, OPCH, RDNT, SHC, BTSG, PRVA, CON, SGRY, and LFSTShould you be buying GeneDx stock or one of its competitors? The main competitors of GeneDx include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. GeneDx vs. Hims & Hers Health Guardant Health Option Care Health RadNet Sotera Health BrightSpring Health Services Privia Health Group Concentra Group Holdings Parent Surgery Partners LifeStance Health Group Hims & Hers Health (NYSE:HIMS) and GeneDx (NASDAQ:WGS) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk, community ranking and dividends. Which has higher earnings & valuation, HIMS or WGS? Hims & Hers Health has higher revenue and earnings than GeneDx. GeneDx is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B5.48-$23.55M$0.5467.40GeneDx$305.45M5.73-$175.77M-$1.96-31.80 Do institutionals & insiders hold more shares of HIMS or WGS? 63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 61.7% of GeneDx shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 27.3% of GeneDx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, HIMS or WGS? Hims & Hers Health has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, GeneDx has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. Is HIMS or WGS more profitable? Hims & Hers Health has a net margin of 8.19% compared to GeneDx's net margin of -17.12%. Hims & Hers Health's return on equity of 10.97% beat GeneDx's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% GeneDx -17.12%3.33%1.69% Does the media refer more to HIMS or WGS? In the previous week, Hims & Hers Health had 32 more articles in the media than GeneDx. MarketBeat recorded 58 mentions for Hims & Hers Health and 26 mentions for GeneDx. GeneDx's average media sentiment score of 1.18 beat Hims & Hers Health's score of 0.64 indicating that GeneDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 26 Very Positive mention(s) 8 Positive mention(s) 13 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive GeneDx 9 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in HIMS or WGS? Hims & Hers Health received 31 more outperform votes than GeneDx when rated by MarketBeat users. However, 48.00% of users gave GeneDx an outperform vote while only 35.25% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes4335.25% Underperform Votes7964.75% GeneDxOutperform Votes1248.00% Underperform Votes1352.00% Do analysts rate HIMS or WGS? Hims & Hers Health presently has a consensus price target of $36.92, indicating a potential upside of 1.44%. GeneDx has a consensus price target of $78.14, indicating a potential upside of 25.39%. Given GeneDx's stronger consensus rating and higher probable upside, analysts plainly believe GeneDx is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 2 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.08GeneDx 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 SummaryHims & Hers Health beats GeneDx on 10 of the 18 factors compared between the two stocks. Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WGS vs. The Competition Export to ExcelMetricGeneDxHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.75B$832.17M$5.54B$7.93BDividend YieldN/A2.55%5.09%4.22%P/E Ratio-31.8052.8822.5518.54Price / Sales5.737.99395.25103.29Price / CashN/A26.1438.1834.62Price / Book7.103.966.764.25Net Income-$175.77M-$5.50M$3.22B$248.18M7 Day Performance-43.86%-3.17%1.37%1.03%1 Month Performance-26.57%2.05%2.77%2.70%1 Year Performance219.59%17.66%15.59%4.05% GeneDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WGSGeneDx2.8602 of 5 stars$64.91+4.1%$78.14+20.4%+197.9%$1.82B$305.45M-33.141,200Earnings ReportAnalyst ForecastInsider TradePositive NewsHIMSHims & Hers Health2.4017 of 5 stars$28.51+1.5%$38.08+33.6%+191.3%$6.33B$1.48B64.80650Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageHigh Trading VolumeGHGuardant Health4.5186 of 5 stars$47.99-0.6%$49.00+2.1%+167.6%$5.92B$739.02M-13.481,790Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpOPCHOption Care Health3.1527 of 5 stars$32.97+0.2%$33.75+2.4%+7.3%$5.42B$5.00B27.715,600Earnings ReportAnalyst UpgradeAnalyst RevisionNews CoveragePositive NewsRDNTRadNet4.0506 of 5 stars$51.03+1.5%$69.75+36.7%+3.5%$3.78B$1.83B-728.908,970Positive NewsSHCSotera Health1.6003 of 5 stars$11.26+1.0%$15.20+35.0%+7.4%$3.20B$1.10B45.043,000Earnings ReportNews CoverageBTSGBrightSpring Health Services1.6207 of 5 stars$17.31+2.3%$21.67+25.2%+67.9%$3.03B$11.27B-66.5835,000News CoveragePositive NewsPRVAPrivia Health Group4.0208 of 5 stars$23.20+0.1%$27.14+17.0%+27.0%$2.81B$1.74B232.02810Upcoming EarningsShort Interest ↓Positive NewsCONConcentra Group Holdings ParentN/A$21.64+1.8%$28.50+31.7%N/A$2.76B$1.90B14.3311,000Upcoming EarningsNews CoveragePositive NewsSGRYSurgery Partners3.2733 of 5 stars$21.56+0.4%$34.75+61.2%-8.9%$2.75B$3.11B-44.9212,200News CoverageLFSTLifeStance Health Group1.4376 of 5 stars$6.53flat$8.30+27.1%+1.1%$2.51B$1.25B-25.126,640Upcoming EarningsPositive News Related Companies and Tools Related Companies HIMS Competitors GH Competitors OPCH Competitors RDNT Competitors SHC Competitors BTSG Competitors PRVA Competitors CON Competitors SGRY Competitors LFST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WGS) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WGS Stock Free WGS Stock Alerts